Drug developer Pfizer Inc. said Wednesday a Spanish court upheld its patent covering the active ingredient in the blockbuster cholesterol drug Lipitor, though it did find a second patent for the drug invalid. The company is facing a generic challenge by drug maker Ranbaxy. Pfizer sells Lipitor in Spain under the names Zarator and Cardyl.
July 25, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Drug developer Pfizer Inc. said Wednesday a Spanish court upheld its patent covering the active ingredient in the blockbuster cholesterol drug Lipitor, though it did find a second patent for the drug invalid.
The company is facing a generic challenge by drug maker Ranbaxy. Pfizer sells Lipitor in Spain under the names Zarator and Cardyl.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
**PLEASE READ THE COMPLETE AD BEFORE APPLYING***Established 25-year boutique Plaintiff's Personal Injury Law Firm in the Dadeland area seeki...
Our client, a multi-state full-service boutique, is seeking to add a senior construction litigation associate to their Florida team. Qualif...
